Today, global biosimulation leader Certara Inc. (NASDAQ: CERT) is rising in premarket trading, up 5.01% to trade at $33.32 at the time of last check-in premarket trading. Yesterday, Certara shares closed the day out at $31.73, giving the stock a -0.25% decline.
CERT stock traded 0.26 million shares compared to the average of 688.68K shares. A price range of $31.19 to $32.54 was seen for CERT stock during the trading session. Prior to this week’s release of quarterly results, the CERT stock is gaining traction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Read More
- Looking For The Best Stocks To Buy For 2021? 3 Electric Vehicle Stocks To Watch
- Top 3 Cosmetics Stocks in the market
When CERT will release financials?
Certara takes medicine research and development to the next level with biosimulation software and technology. In addition to the more than 1,650 global biopharmaceutical companies and leading academic institutions, key regulatory agencies in 61 countries employ CERT.
Certara recently announced that it will release preliminary first-quarter financial results after the market closes on May 6, 2021. CERT Management will hold a conference call at 5:00:00 p.m. ET to discuss the financial results on that day.
What else?
BofA Securities 2021 Virtual Health Care Conference is another event Certara (CERT) will participate in. CERT’s CEO, William Feehery, and CFO, Andrew Schmick, are scheduled to present at 2:45 p.m. ET on May 11, 2021. A live webcast will be broadcasted at CERT’s website and are expected to remain for 90 days afterward.
